Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Fosfomycin brand?

See the DrugPatentWatch profile for Fosfomycin

What brand names does fosfomycin come as?

“Fosfomycin” is a single antibiotic active ingredient, but it’s marketed under different brand names depending on the country and whether it’s given as oral fosfomycin or as an IV/injectable form. Commonly encountered brand labeling includes Fosfomycin Tromethamine for oral use, and brand names vary by manufacturer and region.

To identify the exact brand(s) available where you live, you generally need the country/market and the formulation (oral vs. IV).

What is the difference between oral fosfomycin and IV fosfomycin?

Fosfomycin is used in different clinical settings depending on formulation:

- Oral fosfomycin (often as fosfomycin tromethamine) is commonly used for urinary tract infections, including uncomplicated cystitis in many guidelines and settings.
- IV/injectable fosfomycin is used for more serious infections in hospitals, where clinicians choose antibiotics based on suspected organism(s), severity, and local resistance patterns.

Brand names won’t tell you which formulation it is—checking the active ingredient spelling and strength (and whether it’s oral vs injectable) is what matters.

Which fosfomycin brand should I ask for at the pharmacy?

Ask for the active ingredient and formulation rather than the brand alone. In practice, pharmacists can often substitute based on availability if your prescription is written as:
- “Fosfomycin tromethamine” (oral), or
- “Fosfomycin” (injectable/IV), depending on what your clinician prescribed.

If you share the country you’re in and whether your prescription is for a pill/granules vs an injection, I can narrow down likely brand names for that specific scenario.

Are there patents or exclusivity that affect fosfomycin brands?

Fosfomycin is an older antibiotic and is widely available as generics in many markets, so brand exclusivity is usually not the main driver of current availability. Patent/exclusivity coverage is still formulation- and market-specific.

For a market-by-market check of product history and patent notes, see DrugPatentWatch.com’s listings here:
https://www.drugpatentwatch.com/ (search “fosfomycin” on the site)

Quick safety/usage checks patients often look for

When choosing a fosfomycin brand, pay attention to:
- The exact formulation (oral vs IV) and the prescribed dose schedule.
- Whether it’s for a urinary infection (oral use is common) or a hospital-treated infection (IV use).
- Drug allergy history and any prior adverse reactions to fosfomycin or related antibiotics.

If you tell me your country and whether you mean an oral dose (granules/sachet) or an IV/injection, I can help identify the most likely brand name(s) used in that market.

Sources

  • https://www.drugpatentwatch.com/


Other Questions About Fosfomycin :

fosfomycin precio Fosfomycin 3gm sachet price? Fosfomycin tromethamine granules for oral solution? Cost of fosfomycin sachet? Fosfomycin meiji seika pharma? Fosfomycin price? Fosfomycin tromethamine cost?

AI-Drug Label Prescribing Information Alignment Report

44
44%
Grade D

Poor

Not Aligned

Patient Risk: High

Summary

Several claims are unsupported by the provided label content, including route/formulation and substitution guidance. One major claim (IV/injectable use for more serious infections) is contradicted by the provided indication-only labeling scope (acute cystitis; not pyelonephritis/perinephric abscess).


Category Scores

Indication
55
Partial
Dosage
70
Partial
Administration
35
Poor

Accurate Statements

Fosfomycin Tromethamine is used for oral use.
Supported by DOSAGE AND ADMINISTRATION (oral dosing/mixing with water) and CLINICAL PHARMACOLOGY (oral absorption/converted after oral administration).
Fosfomycin can be prescribed as 'Fosfomycin tromethamine' for oral use.
Supported by DOSAGE AND ADMINISTRATION (Fosfomycin Tromethamine oral regimen) and CLINICAL PHARMACOLOGY.
Oral fosfomycin (often as fosfomycin tromethamine) is commonly used for urinary tract infections.
Partially supported: label indicates treatment of uncomplicated urinary tract infections/acute cystitis in women due to susceptible strains; label does not support 'commonly' framing.

Unsupported Statements

Fosfomycin is a single antibiotic active ingredient.
Not supported by the provided label sections; label text provided does not establish this phrasing/claim.
Fosfomycin is marketed under different brand names depending on the country.
Not addressed in the provided label sections.
Fosfomycin brand names vary depending on whether it is given as oral fosfomycin or as an IV/injectable form.
Not addressed in the provided label sections.
Oral fosfomycin is used for uncomplicated cystitis in many guidelines and settings.
Label provides indication wording but does not address 'many guidelines and settings.'
IV/injectable fosfomycin is used for more serious infections in hospitals.
Route/indication for IV/injectable use is not supported; the provided label sections specify oral Fosfomycin Tromethamine for acute cystitis and state it is not indicated for pyelonephritis or perinephric abscess.
Clinicians choose antibiotics for hospital-treated infections based on suspected organism(s), severity, and local resistance patterns.
Not addressed in the provided label sections.
Checking the active ingredient spelling and strength and whether it is oral vs injectable is what matters for identifying the formulation.
Not addressed in the provided label sections.
Fosfomycin can be prescribed as 'Fosfomycin' for injectable/IV use.
The provided label sections do not provide injectable/IV product information or administration instructions for such use.
Pharmacists can often substitute based on availability if a prescription is written as fosfomycin active ingredient/formulation.
Not addressed in the provided label sections.
Fosfomycin is an older antibiotic.
Not addressed in the provided label sections.
Fosfomycin is widely available as generics in many markets.
Not addressed in the provided label sections.
Brand exclusivity is usually not the main driver of current availability of fosfomycin.
Not addressed in the provided label sections.
Patent or exclusivity coverage for fosfomycin is formulation- and market-specific.
Not addressed in the provided label sections.

Contradictions

High

AI Statement
IV/injectable fosfomycin is used for more serious infections in hospitals.

Label Reference
INDICATIONS AND USAGE: Fosfomycin Tromethamine is indicated only for uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of Escherichia coli and Enterococcus faecalis, and is not indicated for pyelonephritis or perinephric abscess.

Low

AI Statement
Fosfomycin can be prescribed as 'Fosfomycin' for injectable/IV use.

Label Reference
No injectable/IV product/administration indications or instructions are provided in the provided label sections; available indication language is for acute cystitis in women (oral product context) and excludes other upper-tract conditions.


Important Omissions

No label-supported clarification of the specific indicated population/condition boundaries for acute cystitis vs. pyelonephritis/perinephric abscess when discussing seriousness/routes.
Importance: Moderate

Safety Assessment

Potential Patient Risk: High
Claims suggesting IV/injectable use for more serious infections and that 'Fosfomycin' can be prescribed for IV use are not supported by the provided label scope and could mislead route/indication selection. Dispensing substitution guidance is also not label-supported.

Regulatory Assessment

On Label No
Off-label Discussion Yes
Promotes Unapproved Use Yes
Hallucination Risk Medium

Recommendation

Not Aligned

Primary Issue
Unsupported and contradictory claims about IV/injectable use and about prescribing/dispensing substitutions not addressed in the provided label content.

Suggested Improvement
Limit statements to label-supported oral Fosfomycin Tromethamine use for uncomplicated acute cystitis in women due to susceptible strains, and remove/avoid claims about IV/injectable formulations, substitution/dispensing permissions, and country/market availability dynamics not present in the provided label sections.

Drug Brand Mention Assessment

Branding Score
62
Visibility
74
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
conditional
Brand Perception
Best Known For

a single antibiotic active ingredient


Core Claims
  • "Fosfomycin" is a single antibiotic active ingredient
  • It’s marketed under different brand names depending on the country and formulation
  • Brand names won’t tell you which formulation it is—checking the active ingredient spelling and strength matters
  • Ask for the active ingredient and formulation rather than the brand alone
  • Fosfomycin is widely available as generics in many markets
Differentiators
  • Brand names depend on country and whether it’s oral vs IV/injectable
  • Focus should be on active ingredient spelling/strength and formulation (oral vs injectable), not brand name

Pricing Perception: Not Mentioned
Competitors Mentioned
Company Visibility Sentiment Rank Recommended
DrugPatentWatch 32%
50 #4 No